fmoc-val-osu,
130878-68-1,
(S)-2,5-Dioxopyrrolidin-1-yl 2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-methylbutanoate,
MFCD00153370,
Fmoc-L-valine N-Hydroxysuccinimide Ester,
N-Fmoc-L-valine N-succinimidyl ester,
Fmoc-L-Val-OSu,
AK-45756,
SCHEMBL12094357,
KS-00000GBD,
JPJMNCROLRPFHI-QFIPXVFZSA-N,
CS-M3543,
ZINC2526283,
CF-862,
GM2337,
AKOS015904089,
AS-19670,
SC-21000,
AX8131452,
FT-0626514,
ST24026512,
K-4069,
I14-18064,
N-(9H-Fluorene-9-ylmethoxycarbonyl)-L-valine succinimidyl ester,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-valine succinimidyl ester,
2,5-Dioxopyrrolidin-1-yl N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-valinate,
(S)-2,5-dioxopyrrolidin-1-yl 2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-methylbutanoate,
L-Valine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 2,5-dioxo-1-pyrrolidinyl ester,
L-Valine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-,2,5-dioxo-1-pyrrolidinyl ester,
Fmoc-L-valine-osu,
CID11339559,
Fmoc-Val-OSu, 98%, Fmoc-amino acids - 1G 1g,
(2,5-dioxopyrrolidin-1-yl) (2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methyl-butanoate,